Solutions for every CNS research need
From clinical trials to real-world evidence, our AI-powered platform accelerates CNS and psychiatry research with unprecedented precision and compliance.
Streamline Phase I-IV trials with automated data capture, real-time monitoring, and regulatory-ready datasets. Reduce trial timelines by 40% while maintaining full compliance.
- Automated adverse event detection
- Real-time safety monitoring
- SDTM-ready data exports
Generate compelling RWE from routine clinical practice. Transform unstructured clinical notes into structured, analyzable datasets with full provenance tracking.
- Natural language processing
- Longitudinal patient tracking
- Comparative effectiveness research
Accelerate regulatory submissions with audit-ready documentation, automated compliance checks, and standardized data formats that meet FDA and EMA requirements.
- 21 CFR Part 11 compliance
- Automated audit trails
- CDISC standards integration
Support medical affairs teams with real-time insights, publication-ready analyses, and comprehensive safety monitoring across your product portfolio.
- Post-market surveillance
- Medical information requests
- Scientific publication support
Proven across therapeutic areas
Our platform has been validated across multiple CNS and psychiatry indications
Alzheimer's Disease
Cognitive assessments, biomarker tracking, and caregiver-reported outcomes
Depression & Anxiety
Mood tracking, treatment response monitoring, and safety assessments
Parkinson's Disease
Motor symptom tracking, medication adherence, and quality of life measures
Ready to transform your CNS research?
Join leading pharmaceutical companies already using our platform to accelerate their CNS programs.